Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 09, 2021 07:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NABI-HB®

ADMA Expands Commercial IG Product Offering with Additional BIVIGAM and NABI-HB Vial Sizes BIVIGAM 100 mL Vial and NABI-HB 1 mL Vial Now Commercially Available to U.S. Healthcare Providers RAMSEY,...
August 04, 2021 07:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021

RAMSEY, N.J. and BOCA RATON, Fla., Aug. 04, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to...
July 20, 2021 07:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Announces Successful Completion of FDA Pre-Approval Manufacturing Facility Inspection

Approval for VanRx Fill-Finish Machine Expected in the Second Half of 2021 All Supply Chain Robustness Initiatives Remain on Schedule RAMSEY, N.J. and BOCA RATON, Fla., July 20, 2021 (GLOBE...
June 14, 2021 07:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics to Participate in the Raymond James Human Health Innovation Virtual Conference

RAMSEY, N.J. and BOCA RATON, Fla., June 14, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (the “Company”), an end-to-end commercial biopharmaceutical company dedicated to...
May 26, 2021 07:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics to Participate in the Jefferies Virtual Healthcare Conference

RAMSEY, N.J. and BOCA RATON, Fla., May 26, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (the “Company”), an end-to-end commercial biopharmaceutical company dedicated to...
May 12, 2021 16:05 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress and Accomplishments

Achieved First Quarter 2021 Total Revenues of $16.0 Million, a 57% Increase Over First Quarter 2020 Significantly Expanded Total Asset Value to $235.7 Million, Including $94.1 Million in Inventories ...
May 05, 2021 07:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics to Report First Quarter 2021 Financial Results on May 12, 2021

RAMSEY, N.J. and BOCA RATON, Fla., May 05, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing,...
April 28, 2021 07:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Receives FDA Approval for Increased IVIG Production Scale

ADMA Increases Total Forecasted Plant Manufacturing Capacity from 400,000 Liters up to 600,000 Liters and Increases Total Forecasted Peak Revenues in Excess of $300 Million Enhanced Gross Margins and...
April 26, 2021 08:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Opens Newest ADMA BioCenters Plasma Collection Facility in Goose Creek, S.C.

RAMSEY, N.J. and BOCA RATON, Fla. and GOOSE CREEK, S.C., April 26, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated...
April 13, 2021 08:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Infection in Sexual Assault Patients at the 2021 Academy of Managed Care Pharmacy Virtual Annual Meeting

Poster Presentation Highlights the Unmet Patient Need and Medical Cost Burden Associated with Hepatitis B Infection Healthcare Costs Associated with HBV and HIV are Approximately at Parity; HBV...